Insomnia News and Research

Latest Insomnia News and Research

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year.

6 Jul 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

Structures on surface of pneumococci determine bacteria’s ability to cause meningitis

Structures on the surface of pneumococci determine the ability of these bacteria to enter the brain and cause severe infections, according to a paper published in The Journal of Clinical Investigation by researchers at Karolinska Institutet.

29 Jun 2016

Child adversities linked to high rates of adult insomnia

According to a new study, child adversities, which are known to play an important role in mental and physical health, are also associated with poor sleep.

15 Jun 2016

Study characterizes benefits of over-the-counter sleep aid

New research shows that an over-the-counter sleep aid helps people suffering from occasional sleep difficulties fall asleep in less than 20 minutes, on average, and improves their reported quality of sleep.

15 Jun 2016

Natural tendency to self-restrict time in bed can protect against chronic insomnia

Twenty to 50 percent of Americans suffer from acute insomnia each year, defined as difficulty falling asleep or staying asleep, three or more nights per week, for between two weeks and three months.

13 Jun 2016

Almost half of female veterans have insomnia symptoms

A new study sheds light on the prevalence of insomnia symptoms among female veterans. Results demonstrate that more than 47 percent of female veterans reported symptoms of insomnia that resulted in functional impairment. Of this sample group, less than one percent had a diagnosis of a sleep disorder based on medical records.

13 Jun 2016

PD surgery improves quality of life in patients with malignant pleural mesothelioma

Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality of life.

9 Jun 2016

New research offers hope for patients struggling with major depression

A new study reports that approximately two in five adults (39%) who have experienced major depression are able to achieve complete mental health. Researchers consider complete mental health as occurring when people achieve almost daily happiness or life satisfaction, positive social and psychological well-being, and are also free of depression, anxiety, suicidal thoughts and substance abuse for at least one full year.

8 Jun 2016

GFE3 protein may help researchers modify brain activity, memory in targeted ways

Scientists at USC have developed a new tool to modify brain activity and memory in targeted ways, without the help of any drugs or chemicals.

7 Jun 2016

Cobimetinib combined with vemurafenib shows added benefit for melanoma with BRAF V600 mutation

Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.

6 Jun 2016

Military personnel with insomnia symptoms less resilient than members with healthy sleep hygiene

A new study found that military service members who reported insomnia symptoms or short sleep durations were less resilient than members who reported healthy sleep hygiene.

28 May 2016

Study assesses trends in antidepressant prescribing for depression

In a study appearing in the May 24/31 issue of JAMA, Jenna Wong, M.Sc., of McGill University, Montreal, Canada, and colleagues analyzed treatment indications for antidepressants and assessed trends in antidepressant prescribing for depression.

25 May 2016

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Chatting on the phone with a "sleep coach" and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine.

24 May 2016

New BMS survey highlights overlooked needs of women experiencing menopause

A new survey conducted by Ipsos MORI on behalf of the British Menopause Society has revealed that one in two women in Great Britain go through the menopause without consulting a healthcare professional.

20 May 2016

Smartphones may have potential in treatment of insomnia

An investigation published in the current issue of Psychotherapy and Psychosomatics indicates how the smartphone may have a potential in the treatment of insomnia.

10 May 2016

Short sleep duration along with frequent snoring may influence breast cancer survival

A new study reports that short sleep duration combined with frequent snoring reported prior to cancer diagnosis may influence subsequent breast cancer survival.

6 May 2016

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Compared to the nicotine patch and a placebo, the smoking cessation aids varenicline (marketed as Chantix in the U.S.) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events, reports an international team of researchers in a study published online April 22 in the journal The Lancet.

25 Apr 2016

VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).

15 Apr 2016

Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.

12 Apr 2016

Insomnia News and Research

Latest Insomnia News and Research

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Structures on surface of pneumococci determine bacteria’s ability to cause meningitis

Child adversities linked to high rates of adult insomnia

Study characterizes benefits of over-the-counter sleep aid

Natural tendency to self-restrict time in bed can protect against chronic insomnia

Almost half of female veterans have insomnia symptoms

PD surgery improves quality of life in patients with malignant pleural mesothelioma

New research offers hope for patients struggling with major depression

GFE3 protein may help researchers modify brain activity, memory in targeted ways

Cobimetinib combined with vemurafenib shows added benefit for melanoma with BRAF V600 mutation

Military personnel with insomnia symptoms less resilient than members with healthy sleep hygiene

Study assesses trends in antidepressant prescribing for depression

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

New BMS survey highlights overlooked needs of women experiencing menopause

Smartphones may have potential in treatment of insomnia

Short sleep duration along with frequent snoring may influence breast cancer survival

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

Researchers analyze post-Ebola syndrome survivors to improve ongoing treatment

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Insomnia News and Research

Latest Insomnia News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in